During the past decade, Clalit Health Services, Haifa and Western Galilee District conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clalit Health Services, Haifa and Western Galilee District" #1 sponsor was "Clalit Health Services" with 8 trials, followed by "Celgene" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Uzi Milman" with 2 trials sponsored and "CymaBay Therapeutics, Inc." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clalit Health Services, Haifa and Western Galilee District" #1 collaborator was "University of Haifa" with 2 trials as a collaborator, "Clalit Health Services" with 1 trials as a collaborator, "Dept of Family Medicine, Faculty of Medicine, Hebrew University, Jerusalem, Israel" with 1 trials as a collaborator, "Hadassah Medical Organization" with 1 trials as a collaborator and "Rambam Health Care Campus" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Clalit Health Services, Haifa and Western Galilee District" are "Crohn Disease" (3 trials), "Hepatitis C, Chronic" (2 trials), "Low Back Pain" (2 trials), "Obesity" (2 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Clalit Health Services, Haifa and Western Galilee District" in a lesser frequency.

Most popular intervention types in "Clalit Health Services, Haifa and Western Galilee District" are "Drug" (9 trials), "Other" (4 trials), "Behavioral" (3 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "peginterferon alfa-2a [Pegasys]" (2 trials), "Actos" (1 trials) and "COPEGUS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clalit Health Services, Haifa and Western Galilee District" are 15 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clalit Health Services, Haifa and Western Galilee District". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Clalit Health Services, Haifa and Western Galilee District, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Clalit Health Services, Haifa and Western Galilee District, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 7 trials that are defined as “Not Applicable".